Pasar al contenido principal

ESTUDIO ESTRUCTURAL DE LA UNION DE PROTEINAS DE BACTERIOFAGOS A LA PARED CELULAR BACTERIANA

PID2021-125597NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Isolation and characterization of two novel bacteriophages against carbapenem-resistant Klebsiella pneumoniae

  • Senhaji-Kacha, Abrar
  • Bernabéu-Gimeno, Mireia
  • Domingo-Calap, Pilar
  • Aguilera-Correa, John Jairo
  • Seoane-Blanco, Mateo
  • Otaegi-Ugartemendia, Sara
  • Raaij, Mark J. van
  • Esteban, Jaime
  • García-Quintanilla, Meritxell
The data presented in the study are deposited in the GenBank database, the accession numbers of vB_Kpn_F13 and vb_Kpn_F14 are PP341282 and PP341283, respectively., The increase of antibiotic-resistant bacteria has become a global health emergency and the need to explore alternative therapeutic options arises. Phage therapy uses bacteriophages to target specific bacterial strains. Phages are highly specific and can target resistant bacteria. Currently, research in this regard is focused on ensuring reliability and safety to bring this tool into clinical practice. The first step is to conduct comprehensive preclinical research. In this work, we present two novel bacteriophages vB_Kpn_F13 and vB_Kpn_F14 isolated against clinical carbapenem-resistant Klebsiella pneumoniae strains obtained from hospital sewage. Multiple studies in vitro were conducted, such as sequencing, electron microscopy, stability, host range infectivity, planktonic effect and biofilm inhibition in order to discover their ability to be used against carbapenem-resistant K. pneumoniae pathogens causing difficult-to-treat infections., This study has been funded by the Project PI20/00261, Instituto de Salud Carlos III and co-funded by European Union (ESF,“Investing in your future”). MG-Q is supported by the Subprograma Miguel Servet from the Ministerio de Ciencia e Innovación of Spain (MS19/00104), Instituto de Salud Carlos III (Plan Estatal de I+D+i 2017–2020), and co-funded by European Social Fund“Investing in your future”. AS-K is supported by CIBERINFEC-CIBER Enfermedaes Infecciosas (CB21/13/00043). PD-C is supported by the Ramón y Cajal contract RYC2019–028015-I (PDC, MCIN/AEI/10.13039/501100011033, ESF Invest in your future), the Project SEJIGENT/ 2021/014 (PDC, Conselleria d´Innovació, Universitats, Ciència i Societat Digital Generalitat Valenciana) and the Project PID2020–112835RA-Ioo (PDC, MCIN/AEI/10.13039/501100011033). MR is supported by grant PID2021–125597NB-I00 financed by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR and FEDER., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

P3MA: A Promising Mycobacteriophage Infecting Mycobacterium abscessus

  • Broncano-Lavado, Antonio
  • Aguilera-Correa, John Jairo
  • Roquet-Banères, Françoise
  • Kremer, Laurent
  • Mediero, Aránzazu
  • Seoane-Blanco, Mateo
  • van Raaij, Mark J.
  • Pagán, Israel
  • Esteban, Jaime
  • García-Quintanilla, Meritxell
This article belongs to the Special Issue Bacteriophage Therapy a Renaissance Weapon Recent Developments and Application, 2nd Edition., [Background/Objectives:] Mycobacterium abscessus is an opportunistic pathogen causing infections mainly in patients with immunosuppression and chronic pulmonary pathologies. Extended treatment periods are needed to tackle this pathogen, bacterial eradication is rare, and recurrence can take place with time. New alternative treatments are being investigated, such as bacteriophage therapy. This work describes the characterization of the mycobacteriophage P3MA, showing its ability to infect clinical and standard M. abscessus strains., [Methods:] Phylogenetic analysis, electron microscopy, growth curves, biofilm assays, checkerboard, and granuloma-like medium studies were performed., [Results:] P3MA inhibited the growth of clinical samples in both planktonic and biofilm states as well as in a granuloma-like model. The study of the interaction with antibiotics revealed that P3MA exhibited an antagonistic effect combined with clarithromycin, indifference with amikacin, and synergy with imipenem., [Conclusions:] All these results suggest that, after genetic engineering, P3MA could be a promising candidate for phage therapy in combination with imipenem, including lung infections., This research was funded by CIBERINFEC-CIBER de Enfermedaes Infecciosas (CB21/13/00043) and by Vaincre la Mucoviscidose (RF20230503223) and the Association Gregory Lemarchal. M.J.v.R. was supported by grant PID2021–125597NB-I00 financed by MCIN/AEI/10.13039/501100011033 and the European Union Next Generation EU/PRTR and FEDER. M.G.-Q. was supported by the Subprograma Miguel Servet from the Ministerio de Ciencia e Innovación of Spain (CP19/00104), Instituto de Salud Carlos III (Plan Estatal de I + D+i 2017–2020), and co-funded by the European Social Fund “Investing in your future”. I.P. was supported by Ministerio de Ciencia e Innovación (Proyectos de Transición Ecológica y Digital, TED2021-130793B-I00)., Peer reviewed